Repare Therapeutics Inc. Insider Trading for February 2021
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Repare Therapeutics Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Repare Therapeutics Inc. for February 2021.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 18 2021 | RPTX | Repare Therapeutic ... | Versant Vantage I, L.P. | 10% Owner | Sell | J | 0.00 | 745 | 0 | 0 | 745 to 0 (-100.00 %) |
| Feb 18 2021 | RPTX | Repare Therapeutic ... | Versant Vantage I, L.P. | 10% Owner | Buy | J | 0.00 | 745 | 0 | 745 | 0 to 745 |
| Feb 18 2021 | RPTX | Repare Therapeutic ... | Versant Vantage I, L.P. | 10% Owner | Sell | J | 0.00 | 751 | 0 | 0 | 751 to 0 (-100.00 %) |
| Feb 18 2021 | RPTX | Repare Therapeutic ... | Versant Vantage I, L.P. | 10% Owner | Buy | J | 0.00 | 751 | 0 | 751 | 0 to 751 |
| Feb 18 2021 | RPTX | Repare Therapeutic ... | Versant Vantage I, L.P. | 10% Owner | Sell | J | 0.00 | 50,000 | 0 | 458,282 | 508.3 K to 458.3 K (-9.84 %) |
| Feb 18 2021 | RPTX | Repare Therapeutic ... | Versant Vantage I, L.P. | 10% Owner | Sell | J | 0.00 | 5,176 | 0 | 0 | 5.2 K to 0 (-100.00 %) |
| Feb 18 2021 | RPTX | Repare Therapeutic ... | Versant Vantage I, L.P. | 10% Owner | Buy | J | 0.00 | 5,176 | 0 | 5,176 | 0 to 5.2 K |
| Feb 18 2021 | RPTX | Repare Therapeutic ... | Versant Vantage I, L.P. | 10% Owner | Sell | J | 0.00 | 6,000 | 0 | 0 | 6 K to 0 (-100.00 %) |
| Feb 18 2021 | RPTX | Repare Therapeutic ... | Versant Vantage I, L.P. | 10% Owner | Buy | J | 0.00 | 6,000 | 0 | 6,000 | 0 to 6 K |
| Feb 18 2021 | RPTX | Repare Therapeutic ... | Versant Vantage I, L.P. | 10% Owner | Sell | J | 0.00 | 300,000 | 0 | 2,594,451 | 2.9 M to 2.6 M (-10.36 %) |
| Feb 18 2021 | RPTX | Repare Therapeutic ... | Jerel Davis | Director | Sell | J | 0.00 | 745 | 0 | 0 | 745 to 0 (-100.00 %) |
| Feb 18 2021 | RPTX | Repare Therapeutic ... | Jerel Davis | Director | Buy | J | 0.00 | 745 | 0 | 745 | 0 to 745 |
| Feb 18 2021 | RPTX | Repare Therapeutic ... | Jerel Davis | Director | Buy | J | 0.00 | 6 | 0 | 8,906 | 8.9 K to 8.9 K (+0.07 %) |
| Feb 18 2021 | RPTX | Repare Therapeutic ... | Jerel Davis | Director | Sell | J | 0.00 | 751 | 0 | 0 | 751 to 0 (-100.00 %) |
| Feb 18 2021 | RPTX | Repare Therapeutic ... | Jerel Davis | Director | Buy | J | 0.00 | 751 | 0 | 751 | 0 to 751 |
| Feb 18 2021 | RPTX | Repare Therapeutic ... | Jerel Davis | Director | Sell | J | 0.00 | 50,000 | 0 | 458,282 | 508.3 K to 458.3 K (-9.84 %) |
| Feb 18 2021 | RPTX | Repare Therapeutic ... | Jerel Davis | Director | Sell | J | 0.00 | 5,176 | 0 | 0 | 5.2 K to 0 (-100.00 %) |
| Feb 18 2021 | RPTX | Repare Therapeutic ... | Jerel Davis | Director | Buy | J | 0.00 | 5,176 | 0 | 5,176 | 0 to 5.2 K |
| Feb 18 2021 | RPTX | Repare Therapeutic ... | Jerel Davis | Director | Buy | J | 0.00 | 824 | 0 | 8,900 | 8.1 K to 8.9 K (+10.20 %) |
| Feb 18 2021 | RPTX | Repare Therapeutic ... | Jerel Davis | Director | Sell | J | 0.00 | 6,000 | 0 | 0 | 6 K to 0 (-100.00 %) |
| Feb 18 2021 | RPTX | Repare Therapeutic ... | Jerel Davis | Director | Buy | J | 0.00 | 6,000 | 0 | 6,000 | 0 to 6 K |
| Feb 18 2021 | RPTX | Repare Therapeutic ... | Jerel Davis | Director | Sell | J | 0.00 | 300,000 | 0 | 2,594,451 | 2.9 M to 2.6 M (-10.36 %) |
| Feb 18 2021 | RPTX | Repare Therapeutic ... | Versant Ventures V, LLC | 10% Owner | Sell | J | 0.00 | 745 | 0 | 0 | 745 to 0 (-100.00 %) |
| Feb 18 2021 | RPTX | Repare Therapeutic ... | Versant Ventures V, LLC | 10% Owner | Buy | J | 0.00 | 745 | 0 | 745 | 0 to 745 |
| Feb 18 2021 | RPTX | Repare Therapeutic ... | Versant Ventures V, LLC | 10% Owner | Sell | J | 0.00 | 751 | 0 | 0 | 751 to 0 (-100.00 %) |
| Feb 18 2021 | RPTX | Repare Therapeutic ... | Versant Ventures V, LLC | 10% Owner | Buy | J | 0.00 | 751 | 0 | 751 | 0 to 751 |
| Feb 18 2021 | RPTX | Repare Therapeutic ... | Versant Ventures V, LLC | 10% Owner | Sell | J | 0.00 | 50,000 | 0 | 458,282 | 508.3 K to 458.3 K (-9.84 %) |
| Feb 18 2021 | RPTX | Repare Therapeutic ... | Versant Ventures V, LLC | 10% Owner | Sell | J | 0.00 | 5,176 | 0 | 0 | 5.2 K to 0 (-100.00 %) |
| Feb 18 2021 | RPTX | Repare Therapeutic ... | Versant Ventures V, LLC | 10% Owner | Buy | J | 0.00 | 5,176 | 0 | 5,176 | 0 to 5.2 K |
| Feb 18 2021 | RPTX | Repare Therapeutic ... | Versant Ventures V, LLC | 10% Owner | Sell | J | 0.00 | 6,000 | 0 | 0 | 6 K to 0 (-100.00 %) |
| Feb 18 2021 | RPTX | Repare Therapeutic ... | Versant Ventures V, LLC | 10% Owner | Buy | J | 0.00 | 6,000 | 0 | 6,000 | 0 to 6 K |
| Feb 18 2021 | RPTX | Repare Therapeutic ... | Versant Ventures V, LLC | 10% Owner | Sell | J | 0.00 | 300,000 | 0 | 2,594,451 | 2.9 M to 2.6 M (-10.36 %) |
| Feb 10 2021 | RPTX | Repare Therapeutic ... | Forte Steve | EVP, Chief Financia ... | Option Exercise | A | 36.91 | 71,000 | 2,620,610 | 71,000 | |
| Feb 10 2021 | RPTX | Repare Therapeutic ... | Koehler Maria | EVP, Chief Medical ... | Option Exercise | A | 36.91 | 125,000 | 4,613,750 | 125,000 | |
| Feb 10 2021 | RPTX | Repare Therapeutic ... | Zinda Michael | EVP, Chief Science ... | Option Exercise | A | 36.91 | 125,000 | 4,613,750 | 125,000 | |
| Feb 10 2021 | RPTX | Repare Therapeutic ... | Segal Lloyd Mitchell | President and CEO | Option Exercise | A | 36.91 | 125,000 | 4,613,750 | 125,000 | |
| Feb 02 2021 | RPTX | Repare Therapeutic ... | Versant Ventures V, LLC | 10% Owner | Sell | J | 0.00 | 745 | 0 | 0 | 745 to 0 (-100.00 %) |
| Feb 02 2021 | RPTX | Repare Therapeutic ... | Versant Ventures V, LLC | 10% Owner | Buy | J | 0.00 | 745 | 0 | 745 | 0 to 745 |
| Feb 02 2021 | RPTX | Repare Therapeutic ... | Versant Ventures V, LLC | 10% Owner | Sell | J | 0.00 | 751 | 0 | 0 | 751 to 0 (-100.00 %) |
| Feb 02 2021 | RPTX | Repare Therapeutic ... | Versant Ventures V, LLC | 10% Owner | Buy | J | 0.00 | 751 | 0 | 751 | 0 to 751 |
| Feb 02 2021 | RPTX | Repare Therapeutic ... | Versant Ventures V, LLC | 10% Owner | Sell | J | 0.00 | 50,000 | 0 | 508,282 | 558.3 K to 508.3 K (-8.96 %) |
| Feb 02 2021 | RPTX | Repare Therapeutic ... | Versant Ventures V, LLC | 10% Owner | Sell | J | 0.00 | 4,313 | 0 | 0 | 4.3 K to 0 (-100.00 %) |
| Feb 02 2021 | RPTX | Repare Therapeutic ... | Versant Ventures V, LLC | 10% Owner | Buy | J | 0.00 | 4,313 | 0 | 4,313 | 0 to 4.3 K |
| Feb 02 2021 | RPTX | Repare Therapeutic ... | Versant Ventures V, LLC | 10% Owner | Sell | J | 0.00 | 5,000 | 0 | 0 | 5 K to 0 (-100.00 %) |
| Feb 02 2021 | RPTX | Repare Therapeutic ... | Versant Ventures V, LLC | 10% Owner | Buy | J | 0.00 | 5,000 | 0 | 5,000 | 0 to 5 K |
| Feb 02 2021 | RPTX | Repare Therapeutic ... | Versant Ventures V, LLC | 10% Owner | Sell | J | 0.00 | 250,000 | 0 | 2,894,451 | 3.1 M to 2.9 M (-7.95 %) |
| Feb 02 2021 | RPTX | Repare Therapeutic ... | Versant Ventures V, LLC | 10% Owner | Sell | J | 0.00 | 4,328 | 0 | 0 | 4.3 K to 0 (-100.00 %) |
| Feb 02 2021 | RPTX | Repare Therapeutic ... | Versant Ventures V, LLC | 10% Owner | Buy | J | 0.00 | 4,328 | 0 | 4,328 | 0 to 4.3 K |
| Feb 02 2021 | RPTX | Repare Therapeutic ... | Versant Ventures V, LLC | 10% Owner | Sell | J | 0.00 | 20,037 | 0 | 160,958 | 181 K to 161 K (-11.07 %) |
| Feb 02 2021 | RPTX | Repare Therapeutic ... | Versant Ventures V, LLC | 10% Owner | Sell | J | 0.00 | 60,472 | 0 | 0 | 60.5 K to 0 (-100.00 %) |
| Feb 02 2021 | RPTX | Repare Therapeutic ... | Versant Ventures V, LLC | 10% Owner | Buy | J | 0.00 | 1,893 | 0 | 60,472 | 58.6 K to 60.5 K (+3.23 %) |
| Feb 02 2021 | RPTX | Repare Therapeutic ... | Versant Ventures V, LLC | 10% Owner | Sell | J | 0.00 | 8,766 | 0 | 70,422 | 79.2 K to 70.4 K (-11.07 %) |
| Feb 02 2021 | RPTX | Repare Therapeutic ... | Versant Ventures V, LLC | 10% Owner | Buy | J | 0.00 | 1,711 | 0 | 58,579 | 56.9 K to 58.6 K (+3.01 %) |
| Feb 02 2021 | RPTX | Repare Therapeutic ... | Versant Ventures V, LLC | 10% Owner | Sell | J | 0.00 | 7,919 | 0 | 63,619 | 71.5 K to 63.6 K (-11.07 %) |
| Feb 02 2021 | RPTX | Repare Therapeutic ... | Versant Ventures V, LLC | 10% Owner | Buy | J | 0.00 | 56,868 | 0 | 56,868 | 0 to 56.9 K |
| Feb 02 2021 | RPTX | Repare Therapeutic ... | Versant Ventures V, LLC | 10% Owner | Sell | J | 0.00 | 263,278 | 0 | 2,114,947 | 2.4 M to 2.1 M (-11.07 %) |
| Feb 02 2021 | RPTX | Repare Therapeutic ... | Jerel Davis | Director | Sell | J | 0.00 | 745 | 0 | 0 | 745 to 0 (-100.00 %) |
| Feb 02 2021 | RPTX | Repare Therapeutic ... | Jerel Davis | Director | Buy | J | 0.00 | 745 | 0 | 745 | 0 to 745 |
| Feb 02 2021 | RPTX | Repare Therapeutic ... | Jerel Davis | Director | Buy | J | 0.00 | 6 | 0 | 8,076 | 8.1 K to 8.1 K (+0.07 %) |
| Feb 02 2021 | RPTX | Repare Therapeutic ... | Jerel Davis | Director | Sell | J | 0.00 | 751 | 0 | 0 | 751 to 0 (-100.00 %) |
| Feb 02 2021 | RPTX | Repare Therapeutic ... | Jerel Davis | Director | Buy | J | 0.00 | 751 | 0 | 751 | 0 to 751 |
| Feb 02 2021 | RPTX | Repare Therapeutic ... | Jerel Davis | Director | Sell | J | 0.00 | 50,000 | 0 | 508,282 | 558.3 K to 508.3 K (-8.96 %) |
| Feb 02 2021 | RPTX | Repare Therapeutic ... | Jerel Davis | Director | Sell | J | 0.00 | 4,313 | 0 | 0 | 4.3 K to 0 (-100.00 %) |
| Feb 02 2021 | RPTX | Repare Therapeutic ... | Jerel Davis | Director | Buy | J | 0.00 | 4,313 | 0 | 4,313 | 0 to 4.3 K |
| Feb 02 2021 | RPTX | Repare Therapeutic ... | Jerel Davis | Director | Buy | J | 0.00 | 687 | 0 | 8,070 | 7.4 K to 8.1 K (+9.31 %) |
| Feb 02 2021 | RPTX | Repare Therapeutic ... | Jerel Davis | Director | Sell | J | 0.00 | 5,000 | 0 | 0 | 5 K to 0 (-100.00 %) |
| Feb 02 2021 | RPTX | Repare Therapeutic ... | Jerel Davis | Director | Buy | J | 0.00 | 5,000 | 0 | 5,000 | 0 to 5 K |
| Feb 02 2021 | RPTX | Repare Therapeutic ... | Jerel Davis | Director | Sell | J | 0.00 | 250,000 | 0 | 2,894,451 | 3.1 M to 2.9 M (-7.95 %) |
| Feb 02 2021 | RPTX | Repare Therapeutic ... | Jerel Davis | Director | Buy | J | 0.00 | 2,764 | 0 | 7,383 | 4.6 K to 7.4 K (+59.84 %) |
| Feb 02 2021 | RPTX | Repare Therapeutic ... | Jerel Davis | Director | Sell | J | 0.00 | 4,328 | 0 | 0 | 4.3 K to 0 (-100.00 %) |
| Feb 02 2021 | RPTX | Repare Therapeutic ... | Jerel Davis | Director | Buy | J | 0.00 | 4,328 | 0 | 4,328 | 0 to 4.3 K |
| Feb 02 2021 | RPTX | Repare Therapeutic ... | Jerel Davis | Director | Sell | J | 0.00 | 20,037 | 0 | 160,958 | 181 K to 161 K (-11.07 %) |
| Feb 02 2021 | RPTX | Repare Therapeutic ... | Jerel Davis | Director | Buy | J | 0.00 | 1,820 | 0 | 4,619 | 2.8 K to 4.6 K (+65.02 %) |
| Feb 02 2021 | RPTX | Repare Therapeutic ... | Jerel Davis | Director | Sell | J | 0.00 | 60,472 | 0 | 0 | 60.5 K to 0 (-100.00 %) |
| Feb 02 2021 | RPTX | Repare Therapeutic ... | Jerel Davis | Director | Buy | J | 0.00 | 1,893 | 0 | 60,472 | 58.6 K to 60.5 K (+3.23 %) |
| Feb 02 2021 | RPTX | Repare Therapeutic ... | Jerel Davis | Director | Sell | J | 0.00 | 8,766 | 0 | 70,422 | 79.2 K to 70.4 K (-11.07 %) |
| Feb 02 2021 | RPTX | Repare Therapeutic ... | Jerel Davis | Director | Buy | J | 0.00 | 1,711 | 0 | 58,579 | 56.9 K to 58.6 K (+3.01 %) |
| Feb 02 2021 | RPTX | Repare Therapeutic ... | Jerel Davis | Director | Sell | J | 0.00 | 7,919 | 0 | 63,619 | 71.5 K to 63.6 K (-11.07 %) |
| Feb 02 2021 | RPTX | Repare Therapeutic ... | Jerel Davis | Director | Buy | J | 0.00 | 56,868 | 0 | 56,868 | 0 to 56.9 K |
| Feb 02 2021 | RPTX | Repare Therapeutic ... | Jerel Davis | Director | Sell | J | 0.00 | 263,278 | 0 | 2,114,947 | 2.4 M to 2.1 M (-11.07 %) |